Side Effects of DSIP DSIP is not approved for human use, and extensive clinical trials are lacking as of writing
The GLP-1 receptor undergoes a shape change during binding which leads to different biological responses
Most people experience these effects during the first few weeks of treatment, and they often improve as the body adjusts to the medication
This reversal was seen also on the background of the disturbed prostaglandins- and NO-systems, prostaglandins synthesis inhibition as well as NO-overstimulation (NOS-substrate L-arginine) or NO-blockade (N(G)-nitro-L-arginine methyl ester (L-NAME)) (Stupnisek et al., 2012
Sakamoto, K
Important areas to discuss include: Heart disease, heart rhythm concerns, high blood pressure, fainting, or a family history of sudden cardiac death Anxiety, bipolar disorder, psychosis, mania, or other mental health concerns Substance use or a history of medication misuse Tics or Tourettes syndrome Pregnancy, plans to become pregnant, or breastfeeding Other prescription medications, supplements, or substances that could interact with stimulants Vyvanse is a Schedule II controlled medication with a boxed warning for abuse, misuse, and addiction